Interview with the Co-Founder, President and CEO: Equillium Inc. (NASDAQ:EQ)
Bruce Steel, CFA, is a co-founder, Director, President and Chief Executive Officer of Equillium. He is also the founder and Managing Director of BioMed Ventures, the strategic investment arm of BioMed Realty. Since founding BioMed Ventures, Mr. Steel has directed investments in over 30 biotechnology companies including Auspex, AnaptysBio, NeoTract and Receptos. Prior to co-founding Equillium, Mr. Steel was co-founder and CEO of Rincon Pharmaceuticals, a genetic engineering biotechnology company, until its acquisition in 2008; previously he was Chief Business Officer at Anaphore and Head of Corporate Development at Ambit Biosciences. Mr. Steel serves on the board of directors of Breathe Technologies and Aegea Medical, and is a board observer for a number of other private companies. Mr. Steel received his Bachelor of Arts degree from Dartmouth College and Master of Business Administration degree from the Marshall School of Business at the University of Southern California, and he holds the designation of Chartered Financial Analyst. Profile
Word count: 1,793
TWST: Can you give us an overview and history of the company?
Mr. Steel: We started Equillium in 2017 to build a company focused on treating